Nasopharyngeal Carcinoma
Conditions
Interventions
Intervention Group:intervention measures developed based on digital nudging
Control group:routine nursing measures
Sponsors
Chongqing University Cancer Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age 18-70 years; 2. Pathologically confirmed newly diagnosed nasopharyngeal carcinoma of non-keratinizing type (WHO type II/III); 3. Diagnosed with stage II-III according to the 9th edition of the AJCC/UICC clinical staging system; 4. Patients who have completed radical chemoradiotherapy and are planning to take capecitabine oral metronomic chemotherapy; 5. ECOG score: 0-1; 6. Patients able to use WeChat independently on a mobile phone; 7. Subjects must sign an informed consent form and must be willing and able to comply with study visit schedules and other protocol requirements.
Exclusion criteria
Exclusion criteria: 1.Patients intolerant to or allergic to capecitabine; 2.Diseases that may interfere with oral medication therapy, such as dysphagia, chronic diarrhea, or intestinal obstruction; 3.Any severe concurrent diseases that may pose unacceptable risks or affect trial compliance, such as unstable heart disease requiring treatment, renal diseases, chronic hepatitis, poorly controlled diabetes mellitus (fasting blood glucose > 1.5×ULN), mood disorders, etc. 4.Patients without a mobile phone or unable to use WeChat on mobile phones.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Medication proportion of days covered(PDC); | — |
Secondary
| Measure | Time frame |
|---|---|
| Medication Information Reading Rate;Self-reported medication adherence; | — |
Countries
China
Contacts
Public ContactWang Chunyu
Chongqing University Cancer Hospital
Outcome results
None listed